巨细胞动脉炎:全国性人群队列研究揭示发病率、影像诊断与糖皮质激素治疗趋势
这项丹麦全国性人群队列研究纳入1996–2018年9908例新发巨细胞动脉炎(GCA)患者,发现发病率稳定在每10万50岁以上人群19–25例,诊断影像使用从2%升至66%,而颞动脉活检自2016年后骤降,糖皮质激素长期使用比例仍高,与当前国际指南存在明显差距。
要点
- 1996–2018年GCA发病率稳定在19–25/10万(>50岁人群)。
- 诊断影像使用从2000年2%升至2018年66%,颞动脉活检2016年后从70–80%降至29–39%。
- 诊断后2、5、10年仍有64%、40%、34%患者使用糖皮质激素。
核心结论
- 尽管诊断影像使用增加,GCA发病率自1996年以来保持稳定。
- 当前国际GCA治疗指南与截至2018年的临床实践存在明显差距。
研究设计与样本
- 丹麦全国性、基于人群的队列研究,利用医疗与行政登记数据。
- 纳入1996–2018年年龄≥50岁、首次诊断GCA且诊断后6个月内≥3次糖皮质激素处方的患者,共9908例。
主要发现
- GCA发病率在1996–2018年间稳定在每10万>50岁人群19–25例。
- 接受颞动脉活检的比例在2016年前保持稳定,之后从70–80%迅速降至29–39%。
- 接受诊断影像的比例从2000年2%升至2018年66%。
- 诊断后2、5、10年仍接受糖皮质激素治疗的患者比例分别为64%、40%、34%。
- 累积糖皮质激素剂量保持相对稳定。
临床怎么用
- 临床诊断GCA时应关注影像学检查的使用增加及颞动脉活检比例下降的趋势。
- 需重视GCA患者长期糖皮质激素暴露比例仍高,与指南推荐可能存在差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The study investigated the development over time of the incidence, diagnostic imaging, and treatment of giant cell arteritis (GCA). METHOD: This nationwide, population-based cohort study was conducted in Denmark using medical and administrative registries. Incident GCA cases from 1996-2018 were defined as patients aged ≥50 years registered with a first-time GCA diagnosis and ≥3 prescriptions for glucocorticoids (GCs) within 6 months after diagnosis. We determined incidence rates of GCA, the proportion of patients still receiving GCs >2 years after diagnosis, the proportion of patients receiving temporal artery biopsies (TAB) and diagnostic imaging including ultrasound, positron emission tomography, magnetic resonance, and/or computed tomography angiography at the time of diagnosis. RESULTS: We identified 9908 incident GCA cases. The incidence rates of GCA remained stable at 19-25 per 100,000 people aged >50 years from 1996-2018. The proportion of GCA patients receiving a TAB remained constant until 2016, after which it promptly declined from 70-80% to 29-39%. In contrast, the proportion of patients receiving diagnostic imaging increased from 2% to 66% from 2000-2018. The proportion of GCA patients remaining in GC treatment has steadily decreased from 1996-2016, but remains high at 64%, 40%, and 34% after 2, 5, and 10 years following the diagnosis, respectively. The cumulative GC dose has remained relatively stable. CONCLUSION: Incidence rates of GCA have remained stable since 1996 despite increasing use of diagnostic imaging. There is a clear discrepancy between current international GCA treatment guidelines and the clinical practice up to 2018.
引用
- Therkildsen P, de Thurah A, Hansen IT, et al. Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment. Semin Arthritis Rheum. 2021. PMID: 33601192. doi:10.1016/j.semarthrit.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。